Others and our group have reported that MD2 participates in the development of non-alcoholic fatty liver disease, as well as methionine- and choline-deficient diet-induced steatosis and fibrosis [13,14]. Here, LY96 is linked to metabolic dysfunction-associated steatotic liver disease.